Immunohistochemistry baseline patterns identified for the cases where efficacy data were obtained
Case | EGFR | pEGFR | PMAPK | pAkt |
---|---|---|---|---|
Learning set | ||||
198 | ++ | + | ++ | + |
410 | ++ | + | ++ | + |
286 | ++ | − | ++ | − |
140 | − | − | + | − |
163 | + | − | − | − |
287 | + | − | + | − |
253 | + | − | + | − |
194 | − | − | + | − |
265 | ++ | − | ++ | + |
215 | + | − | ++ | − |
Validation set | ||||
219 | + | − | ++ | + |
294 | − | − | ++ | − |
281 | + | − | + | − |
247 | + | − | ++ | + |
185 | ++ | − | ++ | − |
159 | ++ | − | + | − |
354 | − | − | ++ | + |
420 | ++ | − | ++ | − |
NOTE: Sensitive cases are shown in bold.